267 related articles for article (PubMed ID: 10381646)
1. Survival activity of Bcl-2 homologs Bcl-w and A1 only partially correlates with their ability to bind pro-apoptotic family members.
Holmgreen SP; Huang DC; Adams JM; Cory S
Cell Death Differ; 1999 Jun; 6(6):525-32. PubMed ID: 10381646
[TBL] [Abstract][Full Text] [Related]
2. The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4.
Huang DC; Adams JM; Cory S
EMBO J; 1998 Feb; 17(4):1029-39. PubMed ID: 9463381
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the anti-apoptotic mechanism of Bcl-B.
Zhai D; Ke N; Zhang H; Ladror U; Joseph M; Eichinger A; Godzik A; Ng SC; Reed JC
Biochem J; 2003 Nov; 376(Pt 1):229-36. PubMed ID: 12921534
[TBL] [Abstract][Full Text] [Related]
4. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak.
Zong WX; Lindsten T; Ross AJ; MacGregor GR; Thompson CB
Genes Dev; 2001 Jun; 15(12):1481-6. PubMed ID: 11410528
[TBL] [Abstract][Full Text] [Related]
5. Bcl-w forms complexes with Bax and Bak, and elevated ratios of Bax/Bcl-w and Bak/Bcl-w correspond to spermatogonial and spermatocyte apoptosis in the testis.
Yan W; Samson M; Jégou B; Toppari J
Mol Endocrinol; 2000 May; 14(5):682-99. PubMed ID: 10809232
[TBL] [Abstract][Full Text] [Related]
6. Activation of multidomain and BH3-only pro-apoptotic Bcl-2 family members in p53-defective cells.
Paquet C; Schmitt E; Beauchemin M; Bertrand R
Apoptosis; 2004 Nov; 9(6):815-31. PubMed ID: 15505424
[TBL] [Abstract][Full Text] [Related]
7. Bcl-xS and Bad potentiate the death suppressing activities of Bcl-xL, Bcl-2, and A1 in yeast.
Tao W; Kurschner C; Morgan JI
J Biol Chem; 1998 Sep; 273(37):23704-8. PubMed ID: 9726976
[TBL] [Abstract][Full Text] [Related]
8. Expression of genes involved in initiation, regulation, and execution of apoptosis in human neutrophils and during neutrophil differentiation of HL-60 cells.
Santos-Beneit AM; Mollinedo F
J Leukoc Biol; 2000 May; 67(5):712-24. PubMed ID: 10811013
[TBL] [Abstract][Full Text] [Related]
9. Structural biology of the Bcl-2 family of proteins.
Petros AM; Olejniczak ET; Fesik SW
Biochim Biophys Acta; 2004 Mar; 1644(2-3):83-94. PubMed ID: 14996493
[TBL] [Abstract][Full Text] [Related]
10. Pro- and anti-apoptotic members of the Bcl-2 family in skeletal muscle: a distinct role for Bcl-2 in later stages of myogenesis.
Dominov JA; Houlihan-Kawamoto CA; Swap CJ; Miller JB
Dev Dyn; 2001 Jan; 220(1):18-26. PubMed ID: 11146504
[TBL] [Abstract][Full Text] [Related]
11. BCL-2 family expression in human neutrophils during delayed and accelerated apoptosis.
Moulding DA; Akgul C; Derouet M; White MR; Edwards SW
J Leukoc Biol; 2001 Nov; 70(5):783-92. PubMed ID: 11698499
[TBL] [Abstract][Full Text] [Related]
12. Induction of cell death by the BH3-only Bcl-2 homolog Nbk/Bik is mediated by an entirely Bax-dependent mitochondrial pathway.
Gillissen B; Essmann F; Graupner V; Stärck L; Radetzki S; Dörken B; Schulze-Osthoff K; Daniel PT
EMBO J; 2003 Jul; 22(14):3580-90. PubMed ID: 12853473
[TBL] [Abstract][Full Text] [Related]
13. Requirement of A1-a for bacillus Calmette-Guérin-mediated protection of macrophages against nitric oxide-induced apoptosis.
Kausalya S; Somogyi R; Orlofsky A; Prystowsky MB
J Immunol; 2001 Apr; 166(7):4721-7. PubMed ID: 11254733
[TBL] [Abstract][Full Text] [Related]
14. Developmental regulation of Bcl-2 family protein expression in the involuting mammary gland.
Metcalfe AD; Gilmore A; Klinowska T; Oliver J; Valentijn AJ; Brown R; Ross A; MacGregor G; Hickman JA; Streuli CH
J Cell Sci; 1999 Jun; 112 ( Pt 11)(Pt 11):1771-83. PubMed ID: 10318769
[TBL] [Abstract][Full Text] [Related]
15. Expression of Bcl-2 family proteins and association with clinicopathological characteristics of oral squamous cell carcinoma.
Coutinho-Camillo CM; Lourenço SV; Nishimoto IN; Kowalski LP; Soares FA
Histopathology; 2010 Aug; 57(2):304-16. PubMed ID: 20716171
[TBL] [Abstract][Full Text] [Related]
16. harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-X(L).
Inohara N; Ding L; Chen S; Núñez G
EMBO J; 1997 Apr; 16(7):1686-94. PubMed ID: 9130713
[TBL] [Abstract][Full Text] [Related]
17. Dimerization properties of human BAD. Identification of a BH-3 domain and analysis of its binding to mutant BCL-2 and BCL-XL proteins.
Ottilie S; Diaz JL; Horne W; Chang J; Wang Y; Wilson G; Chang S; Weeks S; Fritz LC; Oltersdorf T
J Biol Chem; 1997 Dec; 272(49):30866-72. PubMed ID: 9388232
[TBL] [Abstract][Full Text] [Related]
18. BCL-2: the pendulum of the cell fate.
Blandino G; Strano S
J Exp Clin Cancer Res; 1997 Mar; 16(1):3-10. PubMed ID: 9148853
[TBL] [Abstract][Full Text] [Related]
19. NBK/BIK antagonizes MCL-1 and BCL-XL and activates BAK-mediated apoptosis in response to protein synthesis inhibition.
Shimazu T; Degenhardt K; Nur-E-Kamal A; Zhang J; Yoshida T; Zhang Y; Mathew R; White E; Inouye M
Genes Dev; 2007 Apr; 21(8):929-41. PubMed ID: 17403773
[TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2 interactions.
Finnegan NM; Curtin JF; Prevost G; Morgan B; Cotter TG
Br J Cancer; 2001 Jul; 85(1):115-21. PubMed ID: 11437412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
